The document summarizes guidelines for providing information about diseases and prescription medicines to the public in the Netherlands. It outlines the Dutch regulatory system for pharmaceutical advertising and promotion. The guidelines were developed in response to increased disease awareness campaigns and public demand for prescription medicine information. They establish standards for balanced, complete information about diseases and technical information about prescription medicines. The guidelines apply to all parties providing such information and include conditions like not misleading the public or leading to unnecessary medical treatment. A transitional period was provided for adjusting existing information to the new guidelines.